Product Information
TREMFYA 200 MG/2 ML PEN is a brand product labeled by Janssen Biotech, Inc., priced at $7349.6703 per ML under NDC 57894065102. Its NADAC has been published 28 times since Dec 17, 2025.
Strength
200 mg/2mL
Manufacturer
Janssen Biotech, Inc.NDC
57894065102
Classification
Brand
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Last Updated
2/3/2026
Active Ingredients
GUSELKUMABApproval Type
Biologic (BLA)
FDA Application
BLA761061On Market Since
9/11/2024
Pharmacological Classes
Price Statistics
The NADAC for TREMFYA 200 MG/2 ML PEN has been published 28 times since Dec 17, 2025, and over the history we have for it it has risen 5.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $7349.6703 per ML |
|---|---|
| All-time high | $7349.6703 (Jun 24, 2026) |
| All-time low | $6999.6860 (Dec 17, 2025) |
| 52-week high | $7349.6703 |
| 52-week low | $6999.6860 |
| Median price | $7349.6703 |
| Average price | $7249.6748 |
| Largest weekly change | +5.0% (Feb 11, 2026) |
| Weeks tracked | 28 |
| Tracking since | Dec 17, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the guselkumab market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of TREMFYA 200 MG/2 ML PEN?
The current National Average Drug Acquisition Cost (NADAC) for TREMFYA 200 MG/2 ML PEN, manufactured by Janssen Biotech, Inc., is $7349.6703 per ML (NDC 57894065102), effective Jun 24, 2026.
How has the price of TREMFYA 200 MG/2 ML PEN changed over time?
Over the history we have for it, the NADAC for TREMFYA 200 MG/2 ML PEN has risen 5.0%. It has been tracked across 28 weekly CMS publications since Dec 17, 2025.
What are the highest and lowest recorded NADAC prices for TREMFYA 200 MG/2 ML PEN?
Since Dec 17, 2025, the NADAC for TREMFYA 200 MG/2 ML PEN has ranged from a low of $6999.6860 (Dec 17, 2025) to a high of $7349.6703 (Jun 24, 2026), with a median of $7349.6703 per ML.
Are there cheaper alternatives to TREMFYA 200 MG/2 ML PEN?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of TREMFYA 200 MG/2 ML PEN, so no direct lower-cost alternative is listed.
Who manufactures TREMFYA 200 MG/2 ML PEN?
TREMFYA 200 MG/2 ML PEN (NDC 57894065102) is labeled by Janssen Biotech, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification